These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1293785)

  • 1. [Blood donation in persons older than 65 years].
    Blanco L; Menor MD; García Vela J; Lastra AM
    Sangre (Barc); 1992 Oct; 37(5):412. PubMed ID: 1293785
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood donation centers: new partners in health care access management.
    Orchard W
    NAHAM Manage J; 1992; 17(3):12-3. PubMed ID: 10117164
    [No Abstract]   [Full Text] [Related]  

  • 4. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China].
    Tang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):271-4. PubMed ID: 7511060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a practical autologous blood transfusion program.
    Fleming AW; Green DC; Radcliffe JH; St James DM; Fleming EW
    Am Surg; 1977 Dec; 43(12):794-801. PubMed ID: 596723
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AABB reacts to rise in hepatitis rates.
    Hospitals; 1971 Nov; 45(22):67-70. PubMed ID: 5128764
    [No Abstract]   [Full Text] [Related]  

  • 12. Do patient-related blood donors represent a threat to the safety of the blood supply?
    Pereira A; Sanz C; Tàssies D; Ramírez B
    Haematologica; 2002 Apr; 87(4):427-33. PubMed ID: 11940488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
    Wang JE
    J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
    Pahuja S; Sharma M; Baitha B; Jain M
    Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of viral hepatitis type C in blood donors in Peru].
    Farfán G; Cabezas C
    Rev Gastroenterol Peru; 2003; 23(3):171-6. PubMed ID: 14532917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossing over of autologous and directed donor blood.
    Myhre BA
    Ann Clin Lab Sci; 1992; 22(5):343-52. PubMed ID: 1524404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated risk of transmission of hepatitis C virus by blood transfusion.
    Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
    Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-hepatitis C prevalence and incidence in 2.8 million blood donors in Lower Saxony--residual transfusion-associated HCV risk].
    Diekamp U; Kamutzky K; Windel CD
    Beitr Infusionsther Transfusionsmed; 1997; 34():5-10. PubMed ID: 9417352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texas blood.
    Busby J
    Tex Med; 1991 Oct; 87(10):40-7. PubMed ID: 1962295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.